Matches in SemOpenAlex for { <https://semopenalex.org/work/W4318820281> ?p ?o ?g. }
- W4318820281 endingPage "2718" @default.
- W4318820281 startingPage "2718" @default.
- W4318820281 abstract "In spite of consistent progress at the level of basic research and of clinical treatment, acute myeloid leukemia (AML) still represents an unmet clinical need for adult and pediatric patients. To improve the outcomes of these patients, it is necessary to identify new therapeutic targets. IL3RA (CD123, alpha subunit of the interleukin 3 receptor) is a cell membrane protein overexpressed in several hematologic malignancies, including AML blastic plasmocytoid dendritic cell neoplasms (BPDCN). Given the higher expression of CD123 on leukemic cells compared to normal hematopoietic cells and its low/absent expression on normal hematopoietic stem cells, it appears as a suitable and attractive target for therapy. Various drugs targeting CD123 have been developed and evaluated at clinical level: interleukin-3 conjugated with diphtheria toxin; naked neutralizing anti-CD123 antibodies; drug–antibody conjugates; bispecific antibodies targeting both CD123 and CD3; and chimeric antigen receptor (CAR) T cells engineered to target CD123. Some of these agents have shown promising results at the clinical level, including tagraxofusp (CD123 conjugated with diphtheria toxin) for the treatment of BPDCN and IMGN632 (anti-CD123 drug-conjugate), and flotetuzumab (bispecific anti-CD123 and anti-CD3 monoclonal antibody) for the treatment of AML. However, the therapeutic efficacy of CD123-targeting treatments is still unsatisfactory and must be improved through new therapeutic strategies and combined treatments with other antileukemic drugs." @default.
- W4318820281 created "2023-02-02" @default.
- W4318820281 creator A5009327863 @default.
- W4318820281 creator A5055619996 @default.
- W4318820281 creator A5081938974 @default.
- W4318820281 date "2023-02-01" @default.
- W4318820281 modified "2023-09-30" @default.
- W4318820281 title "CD123 a Therapeutic Target for Acute Myeloid Leukemia and Blastic Plasmocytoid Dendritic Neoplasm" @default.
- W4318820281 cites W1255676896 @default.
- W4318820281 cites W1573679185 @default.
- W4318820281 cites W171830843 @default.
- W4318820281 cites W1915923979 @default.
- W4318820281 cites W1976187277 @default.
- W4318820281 cites W1988356885 @default.
- W4318820281 cites W1989922145 @default.
- W4318820281 cites W1990211056 @default.
- W4318820281 cites W2024570169 @default.
- W4318820281 cites W2027531502 @default.
- W4318820281 cites W2052914628 @default.
- W4318820281 cites W2057168292 @default.
- W4318820281 cites W2069317205 @default.
- W4318820281 cites W2070387456 @default.
- W4318820281 cites W2077488231 @default.
- W4318820281 cites W2096420946 @default.
- W4318820281 cites W2102304044 @default.
- W4318820281 cites W2115492737 @default.
- W4318820281 cites W2120770576 @default.
- W4318820281 cites W2137605834 @default.
- W4318820281 cites W2146300845 @default.
- W4318820281 cites W2158240777 @default.
- W4318820281 cites W2160629041 @default.
- W4318820281 cites W2161090963 @default.
- W4318820281 cites W2259451566 @default.
- W4318820281 cites W2314987545 @default.
- W4318820281 cites W2328509282 @default.
- W4318820281 cites W2342267791 @default.
- W4318820281 cites W2395592928 @default.
- W4318820281 cites W2419140434 @default.
- W4318820281 cites W2486348902 @default.
- W4318820281 cites W2508697147 @default.
- W4318820281 cites W2558106326 @default.
- W4318820281 cites W2564841244 @default.
- W4318820281 cites W2587691649 @default.
- W4318820281 cites W2591153485 @default.
- W4318820281 cites W2735011153 @default.
- W4318820281 cites W2761903029 @default.
- W4318820281 cites W2768799228 @default.
- W4318820281 cites W2787578932 @default.
- W4318820281 cites W2790219752 @default.
- W4318820281 cites W2800912743 @default.
- W4318820281 cites W2806114755 @default.
- W4318820281 cites W2811405063 @default.
- W4318820281 cites W2887523147 @default.
- W4318820281 cites W2898689626 @default.
- W4318820281 cites W2903930842 @default.
- W4318820281 cites W2906083502 @default.
- W4318820281 cites W2906734847 @default.
- W4318820281 cites W2911444815 @default.
- W4318820281 cites W2921261048 @default.
- W4318820281 cites W2939624324 @default.
- W4318820281 cites W2940782615 @default.
- W4318820281 cites W2945573531 @default.
- W4318820281 cites W2951501856 @default.
- W4318820281 cites W2955808891 @default.
- W4318820281 cites W2961062447 @default.
- W4318820281 cites W2969255883 @default.
- W4318820281 cites W2972339682 @default.
- W4318820281 cites W2990086662 @default.
- W4318820281 cites W2991954871 @default.
- W4318820281 cites W3000130289 @default.
- W4318820281 cites W3008284415 @default.
- W4318820281 cites W3011467845 @default.
- W4318820281 cites W3012325124 @default.
- W4318820281 cites W3023646441 @default.
- W4318820281 cites W3025100125 @default.
- W4318820281 cites W3030534638 @default.
- W4318820281 cites W3055875165 @default.
- W4318820281 cites W3081425148 @default.
- W4318820281 cites W3085208365 @default.
- W4318820281 cites W3093280293 @default.
- W4318820281 cites W3093553460 @default.
- W4318820281 cites W3094433457 @default.
- W4318820281 cites W3095159061 @default.
- W4318820281 cites W3120051737 @default.
- W4318820281 cites W3128962475 @default.
- W4318820281 cites W3132281209 @default.
- W4318820281 cites W3134601761 @default.
- W4318820281 cites W3164009880 @default.
- W4318820281 cites W3165390856 @default.
- W4318820281 cites W3181301337 @default.
- W4318820281 cites W3194325204 @default.
- W4318820281 cites W3199284702 @default.
- W4318820281 cites W3212612169 @default.
- W4318820281 cites W3213302192 @default.
- W4318820281 cites W3216289494 @default.
- W4318820281 cites W3216535452 @default.
- W4318820281 cites W3217256511 @default.
- W4318820281 cites W4200430096 @default.